Procter & Gamble (PG)
(Delayed Data from NYSE)
$169.93 USD
+0.82 (0.48%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $170.28 +0.35 (0.21%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$169.93 USD
+0.82 (0.48%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $170.28 +0.35 (0.21%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Zacks News
Church & Dwight (CHD) Q4 Earnings Miss by a Penny, Up Y/Y
by Zacks Equity Research
Church & Dwight (CHD) remains on track to retain its impressive organic sales growth trend in 2019, backed by its solid product launches and investments.
Dow Records Sixth Straight Weekly Gain: 4 Top Picks
by Nalak Das
The Dow starts 2019 with strong momentum.
Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?
by Zacks Equity Research
Sector ETF report for FSTA
Super Bowl Spending, Streaming & Amazon's Big TV Advertising Push
by Benjamin Rains
On this episode of the Full-Court Finance podcast, Associate Stock Strategist Ben Rains dives into the big business behind the Super Bowl as the streaming TV market heats up. Plus, we look at Amazon's huge television advertising push and see who are the biggest Super Bowl spenders.
Clorox (CLX) Earnings Surpass Estimates in Q2, Sales Miss
by Zacks Equity Research
Clorox (CLX) retains forecasts for fiscal 2019, which should benefit from ongoing cost-savings plans.
3 Dividend Growth ETFs & Stocks to Counter Looming Volatility
by Sanghamitra Saha
Weighed down by trade tensions, global growth worries and U.S. government shutdown? Play these dividend growth ETFs and stocks.
Procter & Gamble (PG) Stock Moves -0.09%: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed the most recent trading day at $93.52, moving -0.09% from the previous trading session.
Friday Rally Helps the Markets Recover Earlier Weekly Losses
by David Borun
Positive earnings data and an end to the government shutdown help keep the 2019 rally gooing
Colgate (CL) Q4 Earnings Beat, Soft 2019 View Hurts Stock
by Zacks Equity Research
Colgate's (CL) fourth-quarter 2018 earnings and sales beat estimates on solid organic sales, and improved pricing. However, the company issues a soft earnings view for 2019.
Dow 30 Stock Roundup: UTX, TRV, PG, JNJ Earnings Impress, IBM Revenues Decline Y/Y
by Swarup Gupta
The index traversed an eventful, yet holiday-shortened week.
Zacks Investment Ideas feature highlights: International Business Machines, Procter and Gamble, Ford, Intel and Abbvie
by Zacks Equity Research
Zacks Investment Ideas feature highlights: International Business Machines, Procter and Gamble, Ford, Intel and Abbvie
Stock Market News for Jan 24, 2019
by Zacks Equity Research
Wall Street recovered some of its previous day's losses on Wednesday buoyed by strong fourth quarter earnings results of several major companies
TXN vs. INTC Ahead of Earnings and Reports from IBM, UTX, & More
by Ryan McQueeney
Ryan McQueeney recaps earnings results from IBM, United Technologies, Procter & Gamble, and Comcast. Later, he previews upcoming reports from chip giants Texas Instruments and Intel.
Q4 2018 Earnings in Full Swing
by Zacks Equity Research
Q4 2018 Earnings in Full Swing
Q4 Earnings Roundup: PG, CMCSA, KMB & More
by Mark Vickery
Q4 earnings season continues to shift to a higher gear, and this morning we've got plenty more Q4 reports to tuck into.
Procter & Gamble (PG) Rises on Q2 Earnings Beat, Ups View
by Zacks Equity Research
Organic sales growth across most segments aids Procter & Gamble's (PG) earnings and sales in second-quarter fiscal 2019. The company raises organic sales view for fiscal 2019.
Procter & Gamble (PG) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 3.31% and 1.43%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Blue Chips IBM and Proctor and Gamble Rally on Earnings
by David Borun
Investors are delighted with improved guidance as well as solid earnings
Can Clorox's Strategic Growth Efforts Offset Margin Issues?
by Zacks Equity Research
Clorox (CLX) witnesses strained margins due to higher costs. Nevertheless, its 2020 Strategy and Go Lean initiative to rebuild margins are encouraging.
Why Earnings Season Could Be Great for Procter & Gamble (PG)
by Zacks Equity Research
Procter & Gamble (PG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Procter & Gamble (PG) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Procter & Gamble (PG) have what it takes? Let's find out.
3 Soaps and Cleaning Materials Stocks Set to Beat Q4 Earnings
by Zacks Equity Research
The Soaps and Cleaning Materials industry remains lucrative, backed by product innovation, and cost-saving and restructuring efforts despite soft sales and margins woes.
Key Takeaways from Q4 Earnings Results Thus Far
by Sheraz Mian
First, growth is decelerating. This isn't a surprise, as we knew already that Q4 growth would be materially below the pace set in the first three quarters of the year.
Will Procter & Gamble (PG) Retain Earnings Beat Trend in Q2?
by Zacks Equity Research
Procter & Gamble's (PG) strategic efforts such as product improvement and cost-saving plans are impressive. However, commodity cost inflation and adverse currency remain concerns.
The Zacks Analyst Blog Highlights: Procter & Gamble, NVIDIA, Bristol-Myers, Deere and Ecolab
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Procter & Gamble, NVIDIA, Bristol-Myers, Deere and Ecolab